Finnegan worked closely with Kaken Pharmaceutical and Bausch Health on the recent Kaken v Iancu case, for which the firm received Patent Impact Case of the Year at the 2020 LMG Life Sciences Awards. Finnegan was also recognised as Patent Strategy Firm of the Year.
In this podcast, lead researcher Chris Adams chats to the team about how the case highlights the firm's efforts to align itself with client goals to achieve results.
The discussion covers life sciences in the age of coronavirus through cutting-edge innovations, vaccines and tech. Finnegan talks about training and developing its IP attorneys, and how an IP-driven portfolio must be aligned with business perspectives.
Joining Chris is Rob Gorman, senior vice president and assistant general counsel for Bausch Health, Naoki Yoshida, managing partner of Finnegan’s Tokyo office, and John Livingstone, managing partner of the firm’s Atlanta office.
To find out more about the LMG Life Sciences Awards and the 2020 winners, please visit www.lmglifesciencesawards.com/winners-americas-2020
